至 2028 年亚太地区羊膜产品市场预测 - COVID-19 影响和区域分析 - 按类型 [羊膜(冷冻羊膜和脱水羊膜)和羊膜悬浮液]、应用(伤口护理、骨科、眼科、和其他应用程序)和最终用户(医院和诊所、门诊手术中心和其他最终用户)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 133    |    Report Code: BMIRE00026174    |    Category: Life Sciences

Asia-Pacific Amniotic Products Market

亚太地区羊膜产品市场预计将从2022年的2.5174亿美元增长到<到 2028 年将达到 582.01 亿;预计2022年至2028年复合年增长率为8.8%。

 

再生医学关注的是功能性遭受灾难性损伤和慢性疾病的患者的组织和器官的再生。干细胞研究的显着突破为基于细胞的治疗传统疗法耐药疾病奠定了基础。干细胞因其无限的自我更新和分化成多种类型细胞的能力而成为再生医学的边界。基因编辑和组织工程技术的进步已经认可了将干细胞离体重塑为3D类器官和组织结构以用于定制应用。近年来,干细胞治疗已成为一个有前途且先进的科学研究领域。由于其优异的捕获能力,它还可以用作给药的纳米储库。在临床上,Amnio-M已从用于皮肤和角膜修复的局部应用的简单片材发展到更先进的形式,例如微粉化脱水膜、羊膜细胞因子提取物和用于再生肌肉、软骨和肌腱的溶解粉末注射剂,上个世纪。因此,干细胞研究和再生医学对羊膜的需求不断增加,预计将增加对羊膜产品的需求,从而导致预测期内市场增长。

 

借助新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动亚太地区羊膜产品市场亚太地区羊膜产品市场预计在预测期内将以良好的复合年增长率增长。

2028 年亚太地区羊膜产品市场收入及预测(百万美元)

 

 

 

 

亚太地区羊膜产品市场细分

 

亚太地区羊膜产品市场根据类型分为两部分:应用程序、最终用户和国家/地区。根据类型,市场分为羊膜和羊膜悬浮液。羊膜细分市场将在 2022 年占据市场主导地位,预计在预测期内将增长最快。根据应用,市场分为伤口护理、整形外科、眼科和其他应用。伤口护理细分市场将在 2022 年占据市场主导地位,预计骨科细分市场将在预测期内增长最快。根据最终用户,市场分为医院和诊所、门诊手术中心和其他最终用户。医院和诊所细分市场将在 2022 年占据主导地位,门诊手术中心细分市场预计将在预测期内增长最快。按国家/地区划分,亚太地区羊膜产品市场分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。     

 

Integra生命科学;卡泰娜产品。公司;米梅德克斯; NuVision 生物疗法有限公司;器官发生公司; Sanuwave 和 Sanuwave Health, Inc.;史密斯&侄子;和 Stryker 是亚太地区羊膜产品市场的领先公司之一。



Asia-Pacific Amniotic Products Strategic Insights

Strategic insights for Asia-Pacific Amniotic Products involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-amniotic-products-market-strategic-framework.webp
Get more information on this report

Asia-Pacific Amniotic Products Report Scope

Report Attribute Details
Market size in 2022 US$ 251.74 Million
Market Size by 2028 US$ 582.01 Million
Global CAGR (2022 - 2028) 8.8%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 类型
  • 羊膜
  • 羊膜悬浮液
By 应用
  • 伤口护理
  • 骨科
  • 眼科
  • 其他应用
By 最终用户
  • 医院和诊所
  • 门诊手术中心
  • 其他最终用户
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Integra LifeSciences
  • Katena Products. Inc.
  • MiMedx
  • NuVision Biotherapies Ltd
  • Organogenesis, Inc.
  • Sanuwave and Sanuwave Health, Inc.
  • Smith & Nephew
  • Stryker
  • Get more information on this report

    Asia-Pacific Amniotic Products Regional Insights

    The regional scope of Asia-Pacific Amniotic Products refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-amniotic-products-market-geography.webp
    Get more information on this report

    The List of Companies - Asia-Pacific Amniotic Products Market

    1. Integra LifeSciences
    2. Katena Products. Inc.
    3. MiMedx
    4. NuVision Biotherapies Ltd
    5. Organogenesis, Inc.
    6. Sanuwave and Sanuwave Health, Inc.
    7. Smith & Nephew
    8. Stryker
    Frequently Asked Questions
    How big is the Asia-Pacific Amniotic Products Market?

    The Asia-Pacific Amniotic Products Market is valued at US$ 251.74 Million in 2022, it is projected to reach US$ 582.01 Million by 2028.

    What is the CAGR for Asia-Pacific Amniotic Products Market by (2022 - 2028)?

    As per our report Asia-Pacific Amniotic Products Market, the market size is valued at US$ 251.74 Million in 2022, projecting it to reach US$ 582.01 Million by 2028. This translates to a CAGR of approximately 8.8% during the forecast period.

    What segments are covered in this report?

    The Asia-Pacific Amniotic Products Market report typically cover these key segments-

  • 类型 (羊膜, 羊膜悬浮液)
  • 应用 (伤口护理, 骨科, 眼科, 其他应用)
  • 最终用户 (医院和诊所, 门诊手术中心, 其他最终用户)
  • What is the historic period, base year, and forecast period taken for Asia-Pacific Amniotic Products Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia-Pacific Amniotic Products Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia-Pacific Amniotic Products Market?

    The Asia-Pacific Amniotic Products Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Integra LifeSciences
  • Katena Products. Inc.
  • MiMedx
  • NuVision Biotherapies Ltd
  • Organogenesis, Inc.
  • Sanuwave and Sanuwave Health, Inc.
  • Smith & Nephew
  • Stryker
  • Who should buy this report?

    The Asia-Pacific Amniotic Products Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia-Pacific Amniotic Products Market value chain can benefit from the information contained in a comprehensive market report.